News
Concept Life Sciences celebrates GMP accreditation
Concept Life Sciences (CLS), a Malvern Panalytical brand, has announced that it has received certification of compliance with Good Manufacturing Practice (GMP) for the production...
Clinical Trials
Clovers COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial
Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced that an investigator-led, Phase 2 trial initiated to...
Packaging & Labelling
Tower launches game-changing solution for the transport of ultra cold temperature-critical pharmaceuticals
The launch of the latest solution from pharmaceutical thermal protection specialist Tower Cold Chain is cited as a “game-changer” by customers who have tested...
Press Releases
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY in Children 5 to <12 Years of Age in the European Union
Pfizer Inc. and BioNTech SE announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a...
Drug Research
Nykode Therapeutics Selects BioConnection to Manufacture Lead Vax Candidate
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, announced that it has entered into a...
Drug Research
Lonza and Bioqube Ventures Sign a Framework Agreement for the Future Development of Biologics and Small Molecules for Bioqubes Portfolio Companies
Bioqube Ventures, a European venture capital firm with a dual investment model including venture creation, and Lonza, a global development and manufacturing partner to...
Drug Research
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
Valneva SE, a specialty vaccine company, today announced that it has signed an Advance Purchase Agreement (APA) with the European Commission (EC) to supply...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read